ProPhase CSO and Founder, Dr. Mark Opler, presents at International Society for CNS Drug Development (ISCDD)

ProPhase CSO and Founder, Dr. Mark Opler, presents at International Society for CNS Drug Development (ISCDD)

Dr. Opler led a session on the Collaborative Initiative on New Outcome Measures at the annual meeting of the International Society for CNS Drug Development. The session included an interactive component that provided members a hands-on way to join the New Outcome Measures Initiative. Special focus was on integration of devices and wearables into clinician and patient reported assessments.



Comments are closed.